Company / Operating Income per Share
Krystal Biotech, Inc. Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
$5.60
FY2025
5-year range
-$5.70 / $5.60
FY2021-FY2025
Trend
+140.6%
vs FY2024
Sector context
#15 of 201
Health Care
What the data says
Among 201 Health Care companies, Krystal Biotech, Inc. is in the top 7% for operating income per share. Operating Income per Share has increased for 3 consecutive years, from $-5.70 in FY2022 to $5.60 in FY2025.
Based on SEC 10-K filings.
5.60 in FY2025. Top quartile in the Health Care sector.
Improved from $-4.25 to $5.60 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 7% in Health CareTop 7% of 201This company $5.60 Sector average -$28.56
▼
+119.6% above sector average
Key checks
Key Insights
- Krystal Biotech, Inc.'s operating income per share has grown for 3 consecutive years.
- In FY2025, operating income per share increased 140.6% year-over-year.
- Ranks #15 out of 201 companies in the Health Care sector.
- Lowest operating income per share in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 5.66 (safe zone, above 2.9 threshold)
- Strong profit margin: 30.7%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.60 | +140.6% |
| FY2024 | $2.33 | +154.7% |
| FY2023 | -$4.25 | +25.3% |
| FY2022 | -$5.70 | -85.2% |
| FY2021 | -$3.08 | -75.1% |
| FY2020 | -$1.76 | -26.5% |
| FY2019 | -$1.39 | -30.6% |
| FY2018 | -$1.06 | -19.5% |
| FY2017 | -$0.89 | +31.7% |
| FY2016 | -$1.30 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026